Introduction
The global blood plasma products market has undergone drastic changes from the early days when plasma products were considered unsafe and a threat which can result in spreading of diseases like HIV to a product which now helps in saving lives & treating bleeding disorders and helps people to lead a normal life.

The global plasma products market has more than doubled over the period 2000-08 as a result of increase in demand and prices of plasma products. The worldwide plasma supply has increased but not at the same pace as the demand for the plasma products. The global plasma products market has been segmented on the basis of plasma proteins like immunoglobulin, albumin, clotting factors and other proteins. The IVIG or Immunoglobulin market is the largest segment of the plasma products market having more than fifty percent share of the market. The IVIG and Albumin segment has been real drivers of the global plasma products market as they witnessed double-digit growth rate over the last few years.

The US is the largest market for plasma products consumption as well as in terms of supply of human plasma, as more than fifty percent of global plasma supply comes from the US. The US regulation which allows companies to pay the donor of plasma has significantly contributed towards the high supply of plasma from the US.

Among the emerging markets, China is the most potential target market for plasma products. The market has grown significantly over the last few years. The changes in the Chinese plasma product market have significantly contributed towards the global mismatch of demand and supply of plasma and plasma products.

Despite, challenges like stringent regulations, ensuring adequate supply of human plasma, the global plasma products market is all set to witness high growth in the coming years as a result of growing world population, increasing bleeding disorder patients, rising US heath expenditure and increasing per capita global GDP.

Scope
The current report covers the overview, market size and segmentation of the global blood plasma market. The various drivers, opportunities and the challenges faced by the market are also discussed in detail. The competitive aspect of the market is highlighted and the key players are profiled with their strategies for this market.

Reasons to Purchase
Provides input for strategic business planning
Insights on competitive positioning
Identifies business opportunities & challenges
Analyzes market growth and future trends

Report Highlights

[Studien Infos ausblenden]

TABLE OF CONTENTS
1. Plasma Market

1.1 Overview
1.2 Value-Chain of Plasma market

2. Global Blood Plasma Market

2.1 Market Size
2.2 Market Segmentation

2.2.1. IVIG or Immunoglobulin Market

Market Value
Regional Breakdown

2.2.2 Albumin

Market Value
Price Trend
Regional Breakdown

2.2.3 Clotting Factors

Market Value
Price Trend
Breakdown by Sub-segments

2.2.4 Other Plasma Derived Proteins

2.3 Supply Scenario of Plasma Market

2.3.1 Plasma Supply
2.3.2 Plasma Products Production Capacity

2.4 Industry Cost Structure

3. China Plasma Market

3.1 Market Size
3.2 Supply Scenario
3.3 Regulatory System
3.4 Competitive Scenario

4. Market Movements

4.1 Growth Drivers

4.1.1 Increasing Number of Bleeding Disorder Patients
4.1.2 Rising Aging and Total Global Population
4.1.3 Increasing Per Capita World GDP
4.1.4 U.S. National Health Expenditure

4.2 Challenges

4.2.1 Stricter Regulations
4.2.2 Ensuring Adequate Supply of Plasma
4.2.3 Recombinant Products

5. Competitive Scenario

5.1 Market Share
5.2 Investment Scenario

6. Company Profiles

6.1 Baxter

Business Overview
Business Strategies
Improving Gross Margins
Acquisitions and Investments in Businesses and Technologies

6.2 CSL Ltd

Business Overview
Business Strategies
Increasing Focus on Research & Development
Expansion Strategy

6.3 Talecris

Business Overview
Business Strategies
Vertical Plasma Supply Integration Strategy
Enhance Growth through New Plasma-Derived and Recombinant Proteins

6.4 Octapharma

Business Overview
Business Strategies
Production Efficiency
Plasma Procurement

7. Market Outlook

7.1 Market Forecast

7.2 Forecast Methodology
7.2.1 Dependent and Independent Variables
7.2.2 Correlation Analysis
7.2.3 Regression Analysis
[Inhaltsverzeichnis ausblenden]

Average Industrial Yields for Main Plasma Proteins
Comparison of Blood Products Utilization
Yearly Consumption of the Plasma Products per Million People
Investment strategy of Eight Major Fractionators
Dependent & Independent Variables, 2003– 2008
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output
Blood Constituents
Plasma Constituents
Proteins Present in Human Plasma
Value-Chain of Plasma Derived Products Market
Global Plasma-Derived Products Market, 2000-08
Global Plasma Market by Type of Proteins, 2008
Global Plasma-Derived IVIG Factors Market, 2000-2008
Geographical Break-up of Global IVIG market, 2008
Global Plasma-Derived Human Albumin Factors Market, 2000-2008
Evolution of Global Albumin Prices ($ per g), 1998-2007
Geographical Break-up of Global Albumin Market, 2008
Global Plasma-Derived Clotting Factors Market, 2000-2008
Breakdown of Global Plasma-Derived Clotting Factors Market, 2008
Global Prices of Plasma Derived Factor VIII prices, 1998-2007
Global Plasma-Derived Other Proteins Market, 2000-2008
Worldwide Origin of Plasma, 2002-2008
Plasma Collection by Geographical Area, 2006
Production Capacity of Main Fractionators (million of litres), 2008
Cost structure in Plasma Fractionation Business, 2008
Cost Structure in Pharma Business, 2008
China Plasma Product Market, 2001-2008
Regulations that Limit Raw Material Supply
Plasma Collection Volumes in China, 2003-2009E
New Drug Application (NDA) process: China SFDA Vs US FDA
Breakdown of Chinese Plasma Product Market
Number of Identified Patients (all Bleeding disorders), 1999-2008
Proportion of Old Age and Children Population, 1950-2010E
World Population, 2000-2008
Per Capita World GDP, 2003-2008
U.S. National Health Expenditure, 2000-2008
Global Plasma Fractionation Market, 2008
Plasma Collectors, 2000
Plasma Collectors, 2008
Baxter Company Revenues, 2005-2009
CSL Ltd Revenues, 2005-2009
Talecris Revenues, 2005-2009
Octapharma Revenues, 2004-2008
Global Plasma-derived Products Market Forecast, 2008-2012F
[Tabellenverzeichnis ausblenden]